SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-22-040602
Filing Date
2022-11-09
Accepted
2022-11-09 07:52:47
Documents
7
Period of Report
2022-11-09

Document Format Files

Seq Description Document Type Size
1 6-K brhc10043776_6k.htm 6-K 13649
2 EXHIBIT 99.1 brhc10043776_ex99-1.htm EX-99.1 576717
3 EXHIBIT 99.2 brhc10043776_ex99-2.htm EX-99.2 316337
4 EXHIBIT 99.3 brhc10043776_ex99-3.htm EX-99.3 30759
5 EXHIBIT 99.4 brhc10043776_ex99-4.htm EX-99.4 296936
6 image01.jpg GRAPHIC 17139
7 image02.jpg GRAPHIC 3319
  Complete submission text file 0001140361-22-040602.txt   1263755
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 221370698
SIC: 2834 Pharmaceutical Preparations